Medicare Enrolled
Dr. Katherine Wang, MD, PHD
Hospice and Palliative Medicine (Internal Medicine) Physician · Dallas, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wang? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wang
Dr. Katherine Wang is a hospice and palliative medicine (internal medicine) physician in Dallas, TX, with 19 years in practice. Based on federal Medicare data, Dr. Wang performed 73,402 Medicare services across 3,039 unique beneficiaries.
Between the years covered by Open Payments, Dr. Wang received a total of $199,104 from 61 pharmaceutical and/or device companies across 413 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hospice and palliative medicine (internal medicine) physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wang is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 3% volume in TX$ $199,104 industry payments
Medicare Practice Summary
Medicare Utilization ↗73,402
Medicare services
Top 3% in TX for hospice and palliative medicine (internal medicine) physician
3,039
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,863 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia | 14,855 | $2 | $20 |
| Anti-nausea injection (fosaprepitant) | 12,000 | $0 | $5 |
| Iron sucrose injection (Venofer) | 11,900 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 8,600 | $43 | $136 |
| Paclitaxel chemotherapy injection | 6,742 | $0 | $8 |
| Oxaliplatin chemotherapy injection | 6,250 | $0 | $33 |
| Immune globulin infusion (Octagam) | 1,760 | $33 | $233 |
| Dexamethasone injection (steroid) | 1,607 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,100 | $1 | $114 |
| Blood draw (venipuncture) | 1,088 | $8 | $20 |
| Complete blood count (CBC) with differential | 983 | $8 | $36 |
| Comprehensive metabolic blood panel | 937 | $10 | $64 |
| Injection, granisetron hydrochloride, 100 mcg | 850 | $0 | $24 |
| Office visit, established patient (30-39 min) | 450 | $94 | $368 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 345 | $22 | $157 |
| Administration of chemotherapy into vein, 1 hour or less | 309 | $102 | $707 |
| Office visit, established patient, complex (40-54 min) | 271 | $137 | $496 |
| Injection, fluorouracil, 500 mg | 235 | $2 | $13 |
| Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 228 | $84 | $1,348 |
| Injection, zoledronic acid, 1 mg | 191 | $6 | $431 |
| Office visit, established patient (20-29 min) | 178 | $63 | $250 |
| Injection, carboplatin, 50 mg | 175 | $2 | $300 |
| Lactate dehydrogenase (enzyme) level | 163 | $6 | $31 |
| Drug injection, under skin or into muscle | 161 | $11 | $96 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 140 | $49 | $313 |
| Injection of additional new drug or substance into vein | 117 | $12 | $108 |
| Ferritin level test (iron stores) | 113 | $13 | $60 |
| Infusion, normal saline solution , 1000 cc | 113 | $2 | $19 |
| Injection, diphenhydramine hcl, up to 50 mg | 109 | $1 | $7 |
| Iron level test | 106 | $6 | $27 |
| Iron binding capacity test | 106 | $9 | $35 |
| Microscopic examination for white blood cells with manual cell count | 106 | $4 | $22 |
| Complete blood count (CBC), automated | 106 | $6 | $34 |
| Measurement of immunoglobulin light chains | 102 | $17 | $60 |
| Administration of chemotherapy into vein, each additional hour | 84 | $21 | $161 |
| Hospital follow-up visit, moderate complexity | 77 | $62 | $247 |
| Administration of additional new drug or substance into vein, 1 hour or less | 75 | $51 | $344 |
| Immunoglobulin level test | 67 | $9 | $56 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 66 | $56 | $211 |
| Unclassified drugs | 61 | $1 | $8 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 58 | $20 | $128 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 55 | $16 | $100 |
| Hospital follow-up visit, high complexity | 42 | $94 | $357 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 37 | $1 | $19 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 32 | $131 | $500 |
| Infusion into a vein for hydration, 31-60 minutes | 29 | $24 | $256 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 25 | $27 | $145 |
| Injection, lorazepam, 2 mg | 25 | $1 | $3 |
| Infusion into a vein for hydration, each additional hour | 24 | $10 | $75 |
| New patient office visit (45-59 min) | 24 | $107 | $565 |
| Hospital follow-up visit, low complexity | 20 | $39 | $135 |
| PSA test (prostate cancer screening) | 19 | $18 | $94 |
| Application of on-body injector for under skin injection | 19 | $15 | $96 |
| New patient office visit, complex (60-74 min) | 18 | $162 | $709 |
| Initial hospital admission, high complexity | 18 | $130 | $694 |
| Drawing of blood for a medical problem | 16 | $61 | $264 |
| Initial hospital admission, moderate complexity | 15 | $102 | $470 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.5% high complexity
89.4% medium
7.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$199,104
Total received (2018-2024)
Avg $28,443/year across 7 years
Top 0% in TX for hospice and palliative medicine (internal medicine) physician
61
Companies
413
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$148,824 (74.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$46,321 (23.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,959 (2.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$31,604
2023$20,593
2022$46,252
2021$15,350
2020$22,709
2019$34,006
2018$28,590
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$43,581
AstraZeneca Pharmaceuticals LP
$25,241
Immunocore Limited
$24,221
Incyte Corporation
$11,772
GENZYME CORPORATION
$9,584
Janssen Scientific Affairs, LLC
$9,049
Celgene Corporation
$8,277
Verastem, Inc.
$7,920
Lilly USA, LLC
$7,424
Kite Pharma, Inc.
$6,699
TESARO, Inc.
$6,061
AbbVie, Inc.
$5,477
Karyopharm Therapeutics Inc.
$3,569
Gilead Sciences, Inc.
$2,865
Daiichi Sankyo Inc.
$2,738
Takeda Pharmaceuticals U.S.A., Inc.
$2,494
Bayer HealthCare Pharmaceuticals Inc.
$2,101
ARRAY BIOPHARMA INC
$1,890
AbbVie Inc.
$1,800
Janssen Biotech, Inc.
$1,695
CHIESI USA, INC.
$1,605
Seattle Genetics, Inc.
$1,548
Blueprint Medicines Corporation
$1,526
Seagen Inc.
$1,410
AstraZeneca UK Limited
$1,335
CTI BioPharma Corp.
$1,250
BeiGene USA, Inc.
$1,150
ABBVIE INC.
$998
EUSA Pharma (US) LLC
$900
Astellas Pharma US Inc
$521
BeiGene, Ltd.
$450
Ipsen Biopharmaceuticals, Inc
$246
Amgen Inc.
$170
Athenex Pharmaceutical Division, LLC
$164
Pharmacyclics LLC, An AbbVie Company
$137
ADC Therapeutics America, Inc.
$132
Janssen Pharmaceuticals, Inc
$118
Clovis Oncology, Inc.
$117
GlaxoSmithKline, LLC.
$103
Cardinal Health 110 LLC
$100
Merck Sharp & Dohme LLC
$91
PFIZER INC.
$87
Merck Sharp & Dohme Corporation
$61
Novartis Pharmaceuticals Corporation
$55
Eisai Inc.
$47
Aveo Pharmaceuticals, Inc.
$42
Regeneron Pharmaceuticals, Inc.
$41
Tempus AI, Inc
$29
TerSera Therapeutics LLC
$28
Stemline Therapeutics Inc.
$24
Sirtex Medical Inc
$23
Epizyme, Inc.,
$22
Regeneron Healthcare Solutions, Inc.
$21
Puma Biotechnology, Inc.
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
SOBI, INC
$15
180 Medical, Inc.
$15
Foundation Medicine, Inc.
$14
SERVIER PHARMACEUTICALS LLC
$13
APO-PHARMA USA, INC.
$3
EMD Serono, Inc.
$3
Top 3 companies account for 46.7% of total payments
Associated products mentioned in payments ›
ADCETRIS · AYVAKIT · Aliqopa · BRAFTOVI · BRUKINSA · Bavencio · CALQUENCE · Copiktra · DARZALEX · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · EMPLICITI · Enhertu · Erleada · FASLODEX · FERRIPROX · FOTIVDA · FOUNDATIONONE · FRUZAQLA · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KIMMTRAK · LIBTAYO · LUMAKRAS · LYNPARZA · Lenvima · OJJAARA · ONIVYDE · OPDIVO · Onivyde · Oraxol · PIQRAY · PROMACTA · Pomalyst · REBLOZYL · RYBREVANT · Revlimid · Rubraca · SIR-Spheres Microspheres · SPRYCEL · SYLVANT · TAZVERIK · TECVAYLI · TUKYSA · Tibsovo · VARUBI · VENCLEXTA · VERZENIO · VONJO · Venclexta · Vitrakvi · Vonjo · Vyloy · XARELTO · XOSPATA · XPOVIO · Xofigo · YERVOY · Yescarta · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (75%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 0% for hospice and palliative medicine (internal medicine) physician in TX.
Equivalent to $271 per 100 Medicare services performed
Geographic Context
Hospice and Palliative Medicine (Internal Medicine) Physicians within 10 mi
26
Per 100K population
1.0
County median income
$74,149
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Wang is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), and high industry engagement (consulting-driven, top 0%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Wang experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Wang performed 14,855 darbepoetin injection (aranesp) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wang receive payments from pharmaceutical companies?
Yes. Dr. Wang received a total of $199,104 from 61 companies across 413 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wang's costs compare to other hospice and palliative medicine (internal medicine) physicians in Dallas?
Dr. Wang's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hospice and Palliative Medicine (Internal Medicine) Physicians in Dallas
Browse hospice and palliative medicine (internal medicine) physicians in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Hospice and Palliative Medicine (Internal Medicine) Physicians in TX
Hospice and Palliative Medicine (Internal Medicine) Physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hospice and Palliative Medicine (Internal Medicine) Physicians in TX
Which TX hospice and palliative medicine (internal medicine) physicians receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Immunocore Limited Payments to Doctors
See all physicians who received payments from Immunocore Limited.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology